Cargando…
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
Among the multiple uncertainties surrounding the novel coronavirus disease (COVID-19) pandemic, a research letter published in The Lancet implicated drugs that antagonize the renin-angiotensin-aldosterone system (RAAS) in an unfavorable prognosis of COVID-19. This report prompted investigations to i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculdade de Medicina / USP
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009081/ https://www.ncbi.nlm.nih.gov/pubmed/33852652 http://dx.doi.org/10.6061/clinics/2021/e2342 |